sub field
BiotechLongevity
About
Celine Halioua is the founder and CEO of Loyal, a San Francisco clinical-stage veterinary medicine company developing drugs intended to extend dogs' healthspan and lifespan. She previously worked with Laura Deming at The Longevity Fund and is publicly listed as a Venture Partner there. Her background spans neuroscience, nanobiotechnology, and Oxford research in the economics of gene therapy, with a strong focus on longevity biotech.
Areas of interest
longevitybiotechaging biologytranslational medicinecanine medicinedrug developmentFDA regulatory strategyventure capitalcompany buildinghealth economics